Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03225820 · ClinicalTrials.gov registry record
Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities
A clinical trial of Information Seeking Behavior, sponsored by University of Chicago.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT03225820: Recruiting study of Information Seeking Behavior, sponsored by University of Chicago.
NCT03225820 is a study of Information Seeking Behavior that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 1,000 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03225820, a study of Information Seeking Behavior, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
(a) To explore the feasibility and utility of implementing broad preemptive pharmacogenomic result delivery in the inpatient setting across multiple institutions specifically with the goal of incorporating minority-specific pharmacogenomic information; (b) To determine whether clinical outcomes for the drug warfarin are improved in African Americans through the availability of pharmacogenomics-based dosing guidance at the point-of-care.
Primary Outcome
To explore the feasibility and utility of implementing broad preemptive pharmacogenomic result delivery for African Americans in the inpatient setting across multiple institutions by determining the frequency of Genomic Prescribing System (GPS) use by physicians and pharmacists caring for self-identified African American patients.
Conditions Studied
Study Locations (2)
Illinois
- The University of Illinois at Chicago - Chicago
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-11-09 |
| Est. Completion | 2026-03 |
What NCT03225820 shows while recruiting
NCT03225820 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Information Seeking Behavior appearing as the primary indexed condition, and to 0 interventions.
NCT03225820 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03225820 about?
NCT03225820 is a clinical study titled "Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities". (a) To explore the feasibility and utility of implementing broad preemptive pharmacogenomic result delivery in the inpatient setting across multiple institutions specifically with the goal of incorporating minority-specific pharmacogenomic information; (b) To determine whether clinical outcomes for ...
What is the current status of trial NCT03225820?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-11-09. Estimated completion is 2026-03.
What conditions does trial NCT03225820 study?
This clinical trial studies the following conditions: Information Seeking Behavior.
Who is sponsoring clinical trial NCT03225820?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03225820 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Information Seeking Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI